Shukla Sath

Insider profile

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Shukla Sath's trades of Spero Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-05 2025-02-05 S Sale
93,811 +44.3%
69.78
US$3,782,486
93,811 +44.3% 69.78 US$3,782,486
2025-02-05 2025-02-05 S Sale
76,242 -49.3%
189.95
US$645,829
76,242 -49.3% 189.95 US$645,829
2025-02-05 2025-02-05 S Sale
72,313 +23.4%
290.89
US$3,034,966
72,313 +23.4% 290.89 US$3,034,966
2024-08-29 2024-08-27 S Sale
2,757 -0.2%
1.35
US$3,722
2,757 -0.2% 1.35 US$3,722
2024-08-06 2024-08-05 S Sale
17,641 -1.5%
1.31
US$23,110
17,641 -1.5% 1.31 US$23,110
2024-08-06 2024-08-02 S Sale
14,800 -1.3%
1.32
US$19,536
14,800 -1.3% 1.32 US$19,536
2024-02-05 2024-02-05 PrS Proposed sale
45,093
1.45
US$65,466
45,093 1.45 US$65,466
2024-02-05 2024-02-05 PlS Planned sale
45,093 -3.7%
1.45
US$65,385
45,093 -3.7% 1.45 US$65,385
2024-02-05 2024-02-02 S Sale
30,901 -2.5%
1.37
US$42,334
30,901 -2.5% 1.37 US$42,334
2023-08-30 2023-08-29 PlS Planned sale
4,163 -0.7%
1.30
US$5,412
4,163 -0.7% 1.30 US$5,412
2023-08-29 2023-08-29 PrS Proposed sale
4,163
1.30
US$5,412
4,163 1.30 US$5,412
2023-08-30 2023-08-28 S Sale
1,854 -0.3%
1.26
US$2,336
1,854 -0.3% 1.26 US$2,336
2023-02-03 2023-02-02 PlS Planned sale
9,504 -3.0%
1.83
US$17,372
9,504 -3.0% 1.83 US$17,372
2022-08-30 2022-08-29 PlS Planned sale
6,017 -9.7%
0.89
US$5,378
6,017 -9.7% 0.89 US$5,378